May 2016 Issue Table Of Contents

From The Editor

• Is Going Against The Grain A Good Business Idea?

Feature Articles

• Why Lilly’s Derica Rice Isn’t Your Typical CFO
• Lilly Lives On — And Prospers

Capitol Perspectives

• An Interview With Stephen Ubl, President Of PhRMA

Companies To Watch

• Addex Therapeutics

Inside The Industry

• How 2015’s Patent Law Trends Will Affect Life Sciences Companies
• Singapore’s Evolution To A Top Phase 1 Trial Destination
• Why Now Is The Time For Pharma To Expand Into Africa
• An Entrepreneurial Approach To Funding Drug Development
• The Uphill Battle Toward Innovation For Antibiotic Resistance
• How Purdue Pharma Hopes To Use The Apple ResearchKit
• The Value Of A Dual-Track Process For Raising Capital

Leadership Lessons

• Increasing Self-Awareness In Our Leadership To Drive Organizational Success

Ask The Board

• What Are Some Alternative Security Solutions To Just Using A Security Mark On Packaging?
• Could A Proposal Like The RESULT Act End The FDA’s Monopoly On Approving Drugs?
• What Are Some Best Business Practices That Make Clinical Trial Participants Feel Like Valued Customers?